Body
Findings from a national study published today in the Journal of the American Medical Association (JAMA) "do not support" the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19.
The Outcomes Related to COVID-19 treated with Hydroxychloroquine among In-patients with symptomatic Disease (ORCHID) study found that, when compared to inactive placebo, hydroxychloroquine did not significantly improve clinical outcomes of patients hospitalized for respiratory illness related to COVID-19.
SINGAPORE, 30 October 2020 - Researchers from Duke-NUS Medical School, Erasmus University Medical Center, Yale-NUS College and Duke University have found a potential way to predict who will respond to cancer therapies that block Wnt production, such as the novel made-in-Singapore drug ETC-159. This discovery brings the goal of personalised medicine in cancer therapy a step closer to reality.
SINGAPORE, 14 November 2020 - Patients with chronic kidney disease are more likely to take an active role in managing their health if they have specific information about what to eat, good communication with their doctor, and strong family support, researchers from Duke-NUS Medical School and SingHealth Polyclinics report in the journal BMJ Open.
Leesburg, VA, November 13, 2020--According to an article in ARRS' American Journal of Roentgenology (AJR), positive conclusions--but not titles--were associated with a shorter time from study completion to publication, which may contribute to an overrepresentation of positive results in the imaging diagnostic test accuracy (DTA) literature.
Losing a few kilograms in weight almost halves people's risk of developing Type 2 diabetes - according to a large scale research study led by the Norfolk and Norwich University Hospital and the University of East Anglia.
A new study published in the international journal JAMA Internal Medicine shows how providing support to help people with prediabetes make small changes to their lifestyle, diet and physical activity can almost halve the risk of developing Type 2 diabetes.
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic. This is the first COVID-19-related study where sleep apnea as suspected risk factor emerges as the main finding.
The antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening and may help keep patients out of the hospital, a trial based on research from the University of Virginia School of Medicine suggests.
A research team from the Universitat Rovira i Virgili (Tarragona - Spain) has observed that following a diet rich in fats and sugars from ultra-processed foods (such as sweet rolls and pastries) for a six-week period increases the number of inflammatory molecules in the organism, which increases the excitability of the muscle nerves. This is known as musculoskeletal neurotransmission.
Embargoed until 10:35 a.m. CT/11:35 a.m. ET, Friday, Nov. 13, 2020
Embargoed until 12:30 p.m. CT/1:30 p.m. CT, Friday, Nov. 13, 2020
The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital. It has been theorized that those whose lungs begin to fail are victims of their own overactive immune systems.
Published today in the EClinicalMedicine Journal, a study from the University of Minnesota found that the first four months of the Minnesota Mobile Resuscitation Consortium (MMRC) was 100% effective in cannulation for out-of-hospital sudden cardiac arrests. Cannulation is when tubes are placed in large veins and arteries in the legs, neck or chest in a patient by a health care provider.
(MEMPHIS, Tennessee -- November 13, 2020) Rather than life-threatening hyperinflammation, most adults with moderate-to-severe COVID-19 have a suppressed viral immune response when compared to adults with another viral respiratory infection, influenza. St. Jude Children's Research Hospital and Washington University School of Medicine in St. Louis led research that suggests most COVID-19 patients are not candidates for treatment with steroids such as dexamethasone. The research appears today in Science Advances.
Politicians and governments are suppressing science, and when good science is suppressed, people die, argues a senior editor at The BMJ today.
Executive editor, Dr Kamran Abbasi, argues that covid-19 "has unleashed state corruption on a grand scale, and it is harmful to public health."
A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible allergic reactions.
Yashu Dhamija, MD, a first-year fellow in the UC Division of Immunology, Allergy, and Rheumatology, presented his findings in an abstract while discussing a medically challenging case at the virtual American College of Allergy, Asthma and Immunology (ACAAI) scientific meeting held November 13-15.